InvestorsHub Logo
Followers 19
Posts 816
Boards Moderated 0
Alias Born 02/24/2014

Re: None

Friday, 01/15/2021 9:35:23 AM

Friday, January 15, 2021 9:35:23 AM

Post# of 690618
“The Company is in the process of entering into expanded agreements with certain Scientific Advisory Board members and certain other key consultants whom the Company anticipates will play important roles in helping the Company prepare for potential applications for regulatory approvals of the DCVax-L product. The agreements are being negotiated around structures that are wholly or partly contingent upon major milestones and will provide substantial incentive compensation.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News